Market Overview

Bovie Medical Corporation to Release Second Quarter of Fiscal Year 2018 Financial Results on August 1, 2018


Bovie Medical (NYSE:BVX), a maker of medical devices and supplies and
the developer of J-Plasma®, a patented surgical product
marketed and sold under the Renuvion™ Cosmetic Technology brand in the
cosmetic surgery market, today announced that financial results for the
second quarter of fiscal year 2018 will be released after the market
closes on Wednesday, August 1.

About Bovie Medical Corporation

Bovie Medical Corporation is a leading maker of medical devices and
supplies as well as the developer of J-Plasma® (marketed and sold under
the Renuvion™ Cosmetic Technology brand in the cosmetic surgery market),
a patented plasma-based surgical product for cutting, coagulation and
ablation of soft tissue. J-Plasma/Renuvion technology utilizes a helium
ionization process to produce a stable, focused beam of plasma that
provides surgeons with greater precision, and minimal invasiveness. The
new J-Plasma/Renuvion handpieces with Cool-Coag™ technology deliver the
precision of helium plasma energy, the power of traditional monopolar
coagulation and the efficiency of plasma beam coagulation - enabling
thin-layer ablation and dissection and fast coagulation with a single
instrument, minimizing instrument exchange and allowing a surgeon to
focus on their patient and their procedures. With Cool-Coag technology,
the new J-Plasma/Renuvion handpieces can deliver three distinctly
different energy modalities - further increasing the utility and
versatility of the system. Bovie Medical Corporation is also a leader in
the manufacture of a range of electrosurgical products and technologies,
marketed through both private labels and the Company's own
well-respected brands (Bovie®, IDS™ and DERM™) to distributors
worldwide. The Company also leverages its expertise through original
equipment manufacturing (OEM) agreements with other medical device
manufacturers. For further information about the Company and its
products, please refer to the Bovie Medical Corporation website at

View Comments and Join the Discussion!